OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Hwang on the State of Treatment in Metastatic Prostate Cancer

January 29th 2020

Clara Hwang, MD, a medical oncologist with Henry Ford Health System, discusses the state of treatment in metastatic prostate cancer.

Dr. Taylor on Molecular Testing Recommendations in Ovarian Cancer

January 29th 2020

Sarah E. Taylor, MD, discusses molecular testing recommendations in ovarian cancer.

Dr. Fowler on Selection Criteria for Surgical Procedures in Ovarian Cancer

January 29th 2020

Jeffrey M. Fowler, MD, discusses selection criteria that can help determine which surgical procedure to pursue in ovarian cancer.

Dr. Boisen on Neoadjuvant Chemotherapy Versus Upfront Surgery in Ovarian Cancer

January 29th 2020

Michelle M. Boisen, MD, discusses the selection of neoadjuvant chemotherapy versus upfront surgery for women with newly diagnosed ovarian cancer.

Dr. Mesa on JAK Inhibitors in the Pipeline for Myelofibrosis

January 28th 2020

Ruben A. Mesa, MD, discusses the approval of fedratinib in myelofibrosis and other JAK inhibitors in the treatment pipeline.

Dr. Gerds on Addressing Anemia in Myelofibrosis

January 28th 2020

Aaron Gerds, MD, discusses the adverse event anemia in patients with myelofibrosis.

Dr. Dunavin on Ongoing Research for Myelofibrosis Treatments

January 28th 2020

Neil Dunavin, MD, MS, discusses ongoing research on therapies for patients with myelofibrosis.

Dr. Bauml on the Utility of Liquid Biopsy in Metastatic NSCLC

January 28th 2020

Joshua Bauml, MD, discusses the utility of liquid biopsy in metastatic non–small cell lung cancer.

Dr. Shah on Daratumumab-Based Regimens in Frontline Multiple Myeloma

January 28th 2020

Nina Shah, MD, associate professor of medicine at the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, discusses daratumumab (Darzalex)-based regimens in the frontline treatment of patients with multiple myeloma.

Dr. Vusirikala on Ongoing Research With Blinatumomab in ALL

January 28th 2020

Madhuri Vusirikala, MD, professor of internal medicine in the Division of Hematology/Oncology at the Harold C. Simmons Comprehensive Cancer Center of UT Southwestern Medical Center, discusses ongoing research with blinatumomab (Blincyto) in acute lymphoblastic leukemia (ALL).

Dr. Orr on Ongoing Biomarker Research in Ovarian Cancer

January 28th 2020

Brian Orr, MD, an assistant professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at University of Pittsburgh Medical Center, discusses ongoing biomarker research for immunotherapy in ovarian cancer.

Dr. Yorio on Treatment Options for Patients With Rare Mutations in Metastatic Lung Cancer

January 28th 2020

Jeff Yorio, MD, discusses treatment options for patients with rare mutations in metastatic lung cancer.

Dr. Moses On Ongoing Trials in mHSPC

January 28th 2020

Kelvin Alexander Moses, MD, PhD, discusses ongoing clinical trials in metastatic hormone-sensitive prostate cancer.

Dr. Weber on Adjuvant Approaches in Stage III Melanoma

January 27th 2020

Jeffrey S. Weber, MD, PhD, discusses adjuvant approaches in stage III melanoma.

Dr. Pavlick on Importance of Immunotherapy in Metastatic Melanoma

January 27th 2020

Anna C. Pavlick, DO, discusses the importance of immunotherapy for patients with metastatic melanoma.

Dr. Diefenbach on Polatuzumab Vedotin Plus Obinutuzumab and Lenalidomide in FL

January 27th 2020

Catherine M. Diefenbach, MD, discusses polatuzumab vedotin (Polivy) plus obinutuzumab (Gazyva) and lenalidomide (Revlimid) in patients with follicular lymphoma.

Dr. Penson on Maintaining QoL With AR Inhibitors in Nonmetastatic CRPC

January 25th 2020

David F. Penson, MD, MPH, MMHC, discusses the importance of maintaining quality of life for patients treated with androgen receptor inhibitors in nonmetastatic castration-resistant prostate cancer.

Dr. Cheng on Molecular Testing Considerations in Prostate Cancer

January 25th 2020

Heather H. Cheng, MD, PhD, discusses considerations for molecular testing in prostate cancer.

Dr. Salani on Patient Selection for Primary Debulking Surgery in Ovarian Cancer

January 25th 2020

Ritu Salani, MD, discusses selecting patients with ovarian cancer for primary debulking surgery versus neoadjuvant chemotherapy.

Dr. Shinohara on the Future of Radiation and Surgery in Prostate Cancer

January 25th 2020

Eric Shinohara, MD, MSCI, discusses the future of stereotactic body radiation and surgery in prostate cancer.